Drug & intervention

Humalog

RxCUI 135805

Clinical trials13
Recruiting1
Related conditions9
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Humalog

Wikidata Q29005935 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

13 shown
A Trial of Three- and Seven-days Insulin Infusions SetNCT06532461 · 2024-07-20
RECRUITING
Is Brain Insulin Resistance a Feature of the Biology of Depression in AdolescentsNCT05571878 · 2021-09-01
COMPLETED
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic PancreasNCT03262116 · 2019-03-19
TERMINATED
Environmental Effects Type 1 Diabetes MellitusNCT03102476 · 2016-06-01
COMPLETED
A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 DiabetesNCT02514850 · 2015-07-01
COMPLETED
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin GlargineNCT02294474 · 2015-01-01
COMPLETED
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineNCT02273180 · 2014-10-01
COMPLETED
Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient SurgeryNCT01971047 · 2013-10-01
WITHDRAWN
Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site TolerationNCT01908894 · 2012-02-01
COMPLETED
Effect of Apidra Compared to Humalog in Decreasing Post-Prandial HyperglycemiaNCT01621776 · 2011-06-01
COMPLETED
Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)NCT00916357 · 2009-07-01
COMPLETED
Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes MellitusNCT00774800 · 2008-10-01
COMPLETED
Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20NCT00705536 · 2007-12-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.